In this post, physical therapist Rudy Maltez Alvarez, PT, DPT, discusses how pelvic floor therapy can help people with prostate cancer, including the importance of controlled breathing and how to get started.
Drs. David Ilson, Sumanta (Monty) Pal, and Tian Zhang discuss new research presented at the 2022 ESMO Congress, including studies about treating liver, colorectal, stomach, kidney, bladder, and prostate cancers.
Radiation oncologist and cancer survivor Dr. Arthur Hamberger shares how being diagnosed with cancer led him to a career in oncology, what it was like being diagnosed with multiple cancers 45 years later, and his advice on coping with a cancer diagnosis.
In this webinar, experts discuss new research in bladder cancer, kidney cancer, prostate cancer, and testicular cancer presented at the 2022 ASCO Annual Meeting and the 2022 Genitourinary Cancers Symposium.
Sharie Lisowski shares how she and her husband reacted to his prostate cancer diagnosis and how they worked together to help him choose the best treatment plan for him.
At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider.
Predicting Metastatic Prostate Cancer Risk in a Diverse Population: Research from the 2022 Genitourinary Cancers Symposium
Research from ASCO’s 2022 Genitourinary Cancers Symposium features a study on predicting the risk of developing and dying from metastatic prostate cancer in a diverse population.
In this “Voices on Cancer” post, prostate cancer survivor James E. Williams, Jr., shares how his experience with prostate cancer led him to understand the importance of patient advocacy and inspired him to get involved in bringing awareness to the disease.
In this webinar, experts discuss new research in genitourinary cancers presented at the 2021 ASCO Annual Meeting and the 2021 Genitourinary Cancers Symposium that highlighted advances in treating prostate, bladder, kidney, and testicular cancers.
2021 ASCO Annual Meeting: New Treatments and Research Advances in Esophageal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Kidney Cancer, and Nasopharyngeal Cancer
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer.